Rifamycins: do not throw the baby out with the bathwater. Is rifampicin still an effective anti-tuberculosis drug?

被引：2
作者：
Brucoli, Federico [1 ]
D McHugh, Timothy [2 ]
机构：
[1] De Montfort Univ, Leicester Sch Pharm, Leicester LE1 9BH, Leics, England
[2] UCL, Ctr Clin Microbiol, London NW3 2PF, England
来源：
FUTURE MEDICINAL CHEMISTRY | 2021年 / 13卷 / 24期
关键词：
antimicrobial resistance; first-line TB treatment; rifamycin; TB drug discovery; MYCOBACTERIUM-TUBERCULOSIS; REGIMENS;
D O I：
10.4155/fmc-2021-0249
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
[No abstract available]
引用
收藏
页码：2129 / 2131
页数：3
相关论文
共 14 条
  • [1] Physiological cost of rifampin resistance induced in vitro in Mycobacterium tuberculosis
    Billington, OJ
    McHugh, TD
    Gillespie, SH
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) : 1866 - 1869
  • [2] Structural mechanism for rifampicin inhibition of bacterial RNA polymerase
    Campbell, EA
    Korzheva, N
    Mustaev, A
    Murakami, K
    Nair, S
    Goldfarb, A
    Darst, SA
    [J]. CELL, 2001, 104 (06) : 901 - 912
  • [3] Treatment of Highly Drug-Resistant Pulmonary Tuberculosis
    Conradie, Francesca
    Diacon, Andreas H.
    Ngubane, Nosipho
    Howell, Pauline
    Everitt, Daniel
    Crook, Angela M.
    Mendel, Carl M.
    Egizi, Erica
    Moreira, Joanna
    Timm, Juliano
    McHugh, Timothy D.
    Wills, Genevieve H.
    Bateson, Anna
    Hunt, Robert
    Van Niekerk, Christo
    Li, Mengchun
    Olugbosi, Morounfolu
    Spigelman, Melvin
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10) : 893 - 902
  • [4] Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
    Dorman, S. E.
    Nahid, P.
    Kurbatova, E., V
    Phillips, P. P. J.
    Bryant, K.
    Dooley, K. E.
    Engle, M.
    Goldberg, S., V
    Phan, H. T. T.
    Hakim, J.
    Johnson, J. L.
    Lourens, M.
    Martinson, N. A.
    Muzanyi, G.
    Narunsky, K.
    Nerette, S.
    Nguyen, N., V
    Pham, T. H.
    Pierre, S.
    Purfield, A. E.
    Samaneka, W.
    Savic, R. M.
    Sanne, I
    Scott, N. A.
    Shenje, J.
    Sizemore, E.
    Vernon, A.
    Waja, Z.
    Weiner, M.
    Swindells, S.
    Chaisson, R. E.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (18) : 1705 - 1718
  • [5] Revolutionary new treatment regimens for multidrug-resistant tuberculosis
    McHugh, Timothy D.
    Honeyborne, Isobella
    Lipman, Marc
    Zumla, Alimuddin
    [J]. LANCET INFECTIOUS DISEASES, 2019, 19 (03) : 233 - 234
  • [6] Mitchison DA, 2000, INT J TUBERC LUNG D, V4, P796
  • [7] Norval PY, 1999, INT J TUBERC LUNG D, V3, pS292
  • [8] The effect of oxidative stress on the mutation rate of Mycobacterium tuberculosis with impaired catalase/peroxidase function
    O'Sullivan, D. M.
    McHugh, T. D.
    Gillespie, S. H.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2008, 62 (04) : 709 - 712
  • [9] SENSI P, 1983, REV INFECT DIS, V5, pS402
  • [10] Te BrakeLHM., 2021, EUR RESPIR J, V58
12